Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Robert E Marcus"'
Autor:
Carla Casulo, Michael Herold, Wolfgang Hiddemann, Sunil Iyengar, Robert E. Marcus, John F. Seymour, Aino Launonen, Andrea Knapp, Tina G. Nielsen, Farheen Mir
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 23:40-48
Although advanced‑stage follicular lymphoma (FL) is considered incurable, survival has improved with the introduction of the anti-CD20 antibodies, rituximab (R) and obinutuzumab (G). However, FL can undergo histological transformation (HT) to a mor
Autor:
Silvia Montoto, Paolo Corradini, Martin Dreyling, Michele Ghielmini, Eva Kimby, Armando López-Guillermo, Stephen Mackinnon, Robert E. Marcus, Gilles Salles, Harry C Schouten, Anna Sureda, Peter Dreger
Publikováno v:
Haematologica, Vol 98, Iss 7 (2013)
The aim of this project was to define indications for hematopoietic stem cell transplantation in follicular lymphoma in Europe. In the absence of evidence-based data, a RAND-modified Delphi procedure was used by an expert panel. After pre-defining st
Externí odkaz:
https://doaj.org/article/fd6266558d2d499b8e6a046d1ecf0287
Autor:
Judith Trotman, Sally F Barrington, David Belada, Michel Meignan, Robert MacEwan, Carolyn Owen, Václav Ptáčník, András Rosta, Günter R Fingerle-Rowson, Jiawen Zhu, Tina Nielsen, Deniz Sahin, Wolfgang Hiddemann, Robert E Marcus, Andrew Davies, Mark Hertzberg, Andrew Grigg, Paul Cannell, Hang Quach, Stephen Opat, Constantine Tam, Paula Marlton, Ann Janssens, Fritz Offner, Koen Van eygen, Randeep Sangha, Pam Mckay, Jonathan Wilson, Richard Van Der Jagt, Daryl Roitman, Marek Trneny, Jiri Mayer, Katell Le Du, Philippe Solal-Celigny, Guillaume Cartron, Charles Foussard, Norbert Frickhofen, Peter Schmidt, Ullrich Graeven, Tobias Gaska, Rudolf Schlag, Martin Sökler, Gabriele Prange-Krex, Axel Florschütz, Hans-Walter Lindemann, Christoph Schimmelpfennig, Solveig Tonndorf, Mathias Hänel, Georg Hess, Enrico Schalk, Heiko Hütten, Gottfried Doelken, Michael Pfreundschuh, Ulrich Keller, Michael Herold, Roswitha Forstpointner, Ursula Vehling-Kaiser, Martin Hoffmann, Zita Borbenyi, Miklos Udvardy, Judit Demeter, Alessandro Rambaldi, Enrica Morra, Federico Massimo, Ignazio Majolino, Monica Balzarotti, Gianpietro Semenzato, Miguel Angel Canales Albendea, Francisco Javier Peñalver Parraga, Alfonso Soler Campos, Juan Manuel Sancho Cia, Jose Antonio Marquez Navarro, Carlos Grande Garcia, Herman Nilsson-Ehle, Helen Mccarthy, Chris Pocock, Shalal Sadullah, Ram Malladi, John Radford, Ed Kanfer, Anton Kruger, Dominic Culligan, Martin Dyer, Ruth Pettengell, John Seymour, John Gribben, Saad Al-Ismail, Faris Al-Refaie, Norbert Blesing, Christopher Macnamara, Ann O'callaghan, Andrew Haynes, George Follows, Roderick Johnson, David Cunningham, Kristian Bowles, Graham Collins, Eve Gallop-Evans, Stephen Robinson, Chezhian Subash, James Bailey, Viran Holden, Jeffrey Neidhart, Moacyr De Oliveira, Haluk Tezcan, Kevin Kim, Suman Kambhampati, Keith Lanier, John Mcclean, Kensei Tobinai, Kiyohiko Hatake, Michinori Ogura, Toshiki Uchida, Kiyoshi Ando, Tomohiro Kinoshita, Thomas Höhler, Heribert Stauder, Andreas Kirsch, Michael Koenigsmann, Stephan Kremers, Thomas Illmer, Mathias Witzens-Harig, Paul La Roseé, Jan Dürig, Michael Kneba, Manfred Hensel, Stefan Fuxius, Lothar Bergmann, Kai Hübel, Christian Buske, Reinhard Marks, Gerald Wulf, Christian Lerchenmueller, Rudolf Schmits, Mark Reinwald, Eva Lengfelder, Fiona Scott, Takaaki Chou, Masafumi Taniwaki, Isao Yoshida, Kenichi Ishizawa, Naokuni Uike, Nobuhiko Uoshima, Yuri Kamitsuji, Shinsuke Iida, Ken Ohmine, Kisato Nosaka, Kazuhiko Ide, Takayuki Ishikawa, Pierre Desjardins, Nicholas Finn, Jun Zhu, Wei Li, Li Yu, Hanyun Ren, Yuan Kai Shi, Gang Wu, Xiaonan Hong, Qingyuan Zhang, Jifeng Feng, Rong Zhan, Tongyu Lin, Sirpa Leppa, Regis Costello, Adrian Tempescul, Laurence Sanhes, Olivier Tournilhac, Heinz Kirchen, Holger Hebart, Rudolf Weide, Kathleen Jentsch-Ullrich, Irit Avivi, Arnon Nagler, Ronit Gurion, Ofer Shpilberg, Pietro Leoni, Luca Baldini, Olga Samoylova, Alexandr Myasnikov, Tran-Der Tan, Hung Chang, Kyoya Kumagai, Norifumi Tsukamoto, Kunihiro Tsukasaki, Patrick Beatty, Noriko Usui, Koji Izutsu, Tohru Murayama, Tatsuo Ichinohe, Kohmei Kubo, Fumihiro Ishida, J. Thaddeus Beck, Frank Griesinger, Dzhelil Osmanov, Shaker Dakhil, Aline Clavert, Dai Maruyama, Yasuhito Terui, Kazuhito Yamamoto, Ekkehard Eigendorff, Tsutomu Kobayashi, Satoshi Ichikawa, Ilseung Choi, Katsuya Wada, Yoshitaka Kikukawa, Masao Matsuoka, Takayuki Yoshino, Yosuke Minami
Publikováno v:
Lancet Oncology
Lancet Oncology, Elsevier, 2018, 19 (11), pp.1530--1542. ⟨10.1016/S1470-2045(18)30618-1⟩
Trotman, J, Barrington, S F, Belada, D, Meignan, M, MacEwan, R, Owen, C, Ptáčník, V, Rosta, A, Fingerle-Rowson, G R, Zhu, J, Nielsen, T, Sahin, D, Hiddemann, W, Marcus, R E, Davies, A 2018, ' Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM) : secondary analysis of a randomised, phase 3 trial ', The Lancet Oncology, vol. 19, no. 11, pp. 1530-1542 . https://doi.org/10.1016/S1470-2045(18)30618-1
PET investigators from the GALLIUM study 2018, ' Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM) : secondary analysis of a randomised, phase 3 trial ', The Lancet Oncology, vol. 19, no. 11, pp. 1530-1542 . https://doi.org/10.1016/S1470-2045(18)30618-1
Lancet Oncology, Elsevier, 2018, 19 (11), pp.1530--1542. ⟨10.1016/S1470-2045(18)30618-1⟩
Trotman, J, Barrington, S F, Belada, D, Meignan, M, MacEwan, R, Owen, C, Ptáčník, V, Rosta, A, Fingerle-Rowson, G R, Zhu, J, Nielsen, T, Sahin, D, Hiddemann, W, Marcus, R E, Davies, A 2018, ' Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM) : secondary analysis of a randomised, phase 3 trial ', The Lancet Oncology, vol. 19, no. 11, pp. 1530-1542 . https://doi.org/10.1016/S1470-2045(18)30618-1
PET investigators from the GALLIUM study 2018, ' Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM) : secondary analysis of a randomised, phase 3 trial ', The Lancet Oncology, vol. 19, no. 11, pp. 1530-1542 . https://doi.org/10.1016/S1470-2045(18)30618-1
BACKGROUND: Initial results from the ongoing GALLIUM trial have shown that patients with follicular lymphoma have a longer progression-free survival after first-line immunochemotherapy with obinutuzumab than with rituximab. The aim of this secondary
Autor:
M Ladetto, Sabine De Bedout, Qian Shi, Wolfgang Hiddemann, Gilles Salles, Tina Nielsen, Bruce A. Peterson, Eva Kimby, Franck Morschhauser, Emmanuel Gyan, Tommy Fu, Umberto Vitolo, Howard S. Hochster, Michael Herold, Eva Hoster, Daniel J. Sargent, Nancy Valente, Anton Hagenbeek, Nathan Fowler, Christopher R. Flowers, Michele Ghielmini, Emanuele Zucca, Robert E. Marcus
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2017, 35 (5), pp.552-560. ⟨10.1200/JCO.2016.70.8651⟩
Journal of clinical oncology, 35(5), 552-560. American Society of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2017, 35 (5), pp.552-560. ⟨10.1200/JCO.2016.70.8651⟩
Journal of clinical oncology, 35(5), 552-560. American Society of Clinical Oncology
Purpose Follicular lymphoma (FL) is an indolent cancer, with effective but rarely curative treatment options. As a standard study end point for first-line FL therapy, progression-free survival (PFS) requires extended follow-up (median PFS, > 7 years)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f852d75b5702dfc62174ac4eead502d2
https://hal.archives-ouvertes.fr/hal-01800000
https://hal.archives-ouvertes.fr/hal-01800000
Autor:
Andrew Jack, Andrej Vranovsky, Mars B. van ’t Veer, Anton Hagenbeek, I. Teodorovic, Martine Van Glabbeke, Richard Klasa, Marinus H. J. van Oers, Max Wolf, Randy D. Gascoyne, Harald Holte, Robert E. Marcus, Cynthia Rozewicz, Eva Kimby
Publikováno v:
Blood, 108(10), 3295-3301. American Society of Hematology
We evaluated the role of rituximab (R) both in remission induction and maintenance treatment of relapsed/resistant follicular lymphoma (FL). A total of 465 patients were randomized to induction with 6 cycles of cyclophosphamide, doxorubicin, vincrist
Autor:
David A Enoch, Jenny I.O. Craig, James S Cargill, Emma Gudgin, Sandra Young Min, Hugo A. Ludlam, Robert E. Marcus, Charles Crawley, Tony Todd, George A. Follows, Pat Sartori, Martin Besser
Publikováno v:
Journal of Infection. 56:156-158
Autor:
Maher K, Gandhi, Sarath, Lekamwasam, Ingrid, Inman, Stephen, Kaptoge, Lorraine, Sizer, Shirley, Love, Philip W, Bearcroft, Thomas P, Milligan, Christopher P, Price, Robert E, Marcus, Juliet E, Compston
Publikováno v:
British journal of haematology. 121(3)
Reduced bone mineral density (BMD) has been reported following allogeneic stem cell transplantation (alloSCT) but the effects of autologous SCT (autoSCT) are less well characterized. We performed a prospective study of BMD changes and its determinant
Autor:
Harald Holte, Martine Van Glabbeke, Max Wolf, Mars B. van ’t Veer, Andrej Vranovsky, Evelyn Tonissen, Bert A. van der Reijden, Eva Kimby, Richard Klasa, Marinus H. J. van Oers, Robert E. Marcus, Livia Giurgia, Anton Hagenbeek
Publikováno v:
Blood. 110:791-791
Background. The predictive value of assessment of minimal residual disease after induction treatment in follicular lymphoma (FL) is still controversial. Last year we published the results of a prospective randomized phase III intergroup trial evaluat
Autor:
Anton Hagenbeek, Eva Kimby, Max Wolf, Robert E. Marcus, Richard Klasa, Cynthia Rozewicz, Ivana Teodorovic, Martine Van Glabbeke, Marinus H.J. Van Oers
Publikováno v:
Blood. 106:353-353
Background. Last year we reported interim results of a randomised phase III trial in patients with relapsed/refractory stage III/IV positive follicular NHL, demonstrating that the addition of rituximab (R) to CHOP chemotherapy for remission induction
Autor:
Donald McCarthy, David A. G. Galton, Robert E. Marcus, Jane F. Apperley, Finella Brito-Babapulle, Stella J. Bowcock, Fey Rassool, John M. Goldman, AP Guo, Charles Dowding, Daniel Catovsky, K. H. Th'ng
Publikováno v:
British Journal of Haematology. 73:76-81
Summary. We treated 14 patients with Ph-chromosome-positive chronic myeloid leukaemia still in chronic phase by autografting with blood-derived haemopoietic stem cells. Eleven patients were autografted electively after cytoreductive treatment with bu